Portfolio of Bridgewater Associates
Bridgewater Associates was founded by Ray Dalio, who handed over leadership in 2022; the hedge fund follows a macroeconomic approach with a broadly diversified portfolio.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 11, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 23.6B USD
- Positions
- 985
- Share of the ten largest
- 29.4%
The ten largest positions Q2 2022
- Procter & Gamble 4.1%▼ −1.1%
- Johnson & Johnson 3.3%▼ −0.3%
- Ishares Inc 3.2%▼ −4.1%
- SPDR Sp 500 ETF TR 2.9%▼ −2.1%
- Coca-Cola Company (The) 2.9%▼ −9.4%
- Ishares TR 2.7%▲ +51.1%
- Vanguard Intl Equity Index F 2.7%▼ −32.1%
- PepsiCo 2.7%▼ −8.7%
- Costco 2.5%▲ +2.0%
- Walmart 2.4%▲ +16.5%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| PG Procter & Gamble | 4.1% | 6,747,168 | 970.2M USD | −1.1% reduced | Q3 2020 8 quarters |
| JNJ Johnson & Johnson | 3.3% | 4,332,633 | 769.1M USD | −0.3% reduced | Q3 2020 8 quarters |
| Ishares Inc | 3.2% | 15,308,412 | 751.0M USD | −4.1% reduced | Q3 2016 24 quarters |
| SPDR Sp 500 ETF TR | 2.9% | 1,843,262 | 695.4M USD | −2.1% reduced | Q2 2013 or earlier 37 quarters |
| KO Coca-Cola Company (The) | 2.9% | 10,820,759 | 680.7M USD | −9.4% reduced | Q3 2020 8 quarters |
| Vanguard Intl Equity Index F | 2.7% | 15,432,241 | 642.8M USD | −32.1% reduced | Q2 2013 or earlier 37 quarters |
| PEP PepsiCo | 2.7% | 3,808,959 | 634.8M USD | −8.7% reduced | Q3 2020 8 quarters |
| Mcdonalds Corp | 2.2% | 2,071,584 | 511.4M USD | −10.3% reduced | Q3 2020 8 quarters |
| ABT Abbott Laboratories | 1.3% | 2,799,913 | 304.2M USD | −8.1% reduced | Q3 2020 8 quarters |
| PDD PDD Holdings | 1.3% | 4,814,632 | 297.5M USD | −2.5% reduced | Q2 2019 13 quarters |
| SBUX Starbucks | 1.0% | 3,242,719 | 247.7M USD | −1.7% reduced | Q1 2020 10 quarters |
| SPDR Gold TR | 0.9% | 1,306,455 | 220.1M USD | −38.0% reduced | Q2 2017 21 quarters |
| CL Colgate-Palmolive | 0.8% | 2,290,197 | 183.5M USD | −12.8% reduced | Q3 2020 8 quarters |
| PFE Pfizer | 0.7% | 3,017,675 | 158.2M USD | −8.9% reduced | Q1 2021 6 quarters |
| EL Estée Lauder Companies (The) | 0.7% | 612,560 | 156.0M USD | −15.5% reduced | Q3 2020 8 quarters |
| LI Li Auto | 0.5% | 3,267,912 | 125.2M USD | −2.6% reduced | Q1 2021 6 quarters |
| KMB Kimberly-Clark | 0.5% | 901,921 | 121.9M USD | −8.9% reduced | Q3 2020 8 quarters |
| BDX Becton Dickinson | 0.5% | 447,595 | 110.3M USD | −11.2% reduced | Q3 2020 8 quarters |
| STZ Constellation Brands | 0.4% | 413,813 | 96.4M USD | −6.1% reduced | Q1 2020 10 quarters |
| EW Edwards Lifesciences | 0.4% | 995,357 | 94.6M USD | −12.3% reduced | Q3 2020 8 quarters |
| HSY Hershey Company (The) | 0.4% | 427,903 | 92.1M USD | −0.6% reduced | Q1 2020 10 quarters |
| BSX Boston Scientific | 0.4% | 2,314,536 | 86.3M USD | −12.5% reduced | Q3 2020 8 quarters |
| Ishares Gold TR | 0.3% | 2,369,514 | 81.3M USD | −29.3% reduced | Q2 2021 5 quarters |
| YUM Yum! Brands | 0.3% | 664,917 | 75.5M USD | −24.3% reduced | Q3 2020 8 quarters |
| YUMC Yum China | 0.3% | 1,546,980 | 75.0M USD | −4.8% reduced | Q2 2018 17 quarters |
| TCOM Trip.com Group | 0.3% | 2,445,243 | 67.1M USD | −3.1% reduced | Q4 2019 11 quarters |
| LLY Lilly (Eli) | 0.3% | 204,825 | 66.4M USD | −17.2% reduced | Q2 2021 5 quarters |
| CHD Church & Dwight | 0.3% | 702,249 | 65.1M USD | −1.1% reduced | Q1 2020 10 quarters |
| BF-B Brown–Forman | 0.3% | 892,426 | 62.6M USD | −15.4% reduced | Q3 2020 8 quarters |
| BMY Bristol Myers Squibb | 0.2% | 759,007 | 58.4M USD | −4.3% reduced | Q1 2021 6 quarters |
| Ishares TR | 0.2% | 1,435,298 | 57.6M USD | −92.7% reduced | Q2 2013 or earlier 37 quarters |
| BAX Baxter International | 0.2% | 867,608 | 55.7M USD | −8.6% reduced | Q3 2020 8 quarters |
| BEKE KE Holdings | 0.2% | 3,088,335 | 55.4M USD | −11.9% reduced | Q3 2020 8 quarters |
| Ishares TR | 0.2% | 1,612,109 | 54.7M USD | −50.8% reduced | Q2 2019 13 quarters |
| Beigene Ltd | 0.2% | 331,142 | 53.6M USD | −13.7% reduced | Q4 2020 7 quarters |
| Ishares TR | 0.2% | 955,915 | 53.4M USD | −34.2% reduced | Q2 2019 13 quarters |
| Lufax Holding Ltd | 0.2% | 8,870,197 | 53.2M USD | −1.2% reduced | Q4 2020 7 quarters |
| RMD ResMed | 0.2% | 242,921 | 50.9M USD | −10.3% reduced | Q3 2020 8 quarters |
| ZTO ZTO Express | 0.2% | 1,811,900 | 49.7M USD | −4.1% reduced | Q3 2019 12 quarters |
| Kellogg Co | 0.2% | 694,691 | 49.6M USD | −14.7% reduced | Q3 2020 8 quarters |
| IDXX Idexx Laboratories | 0.2% | 137,201 | 48.1M USD | −1.6% reduced | Q3 2020 8 quarters |
| IBM IBM | 0.2% | 312,891 | 44.2M USD | −16.8% reduced | Q4 2021 3 quarters |
| CLX Clorox | 0.2% | 295,162 | 41.6M USD | −5.4% reduced | Q1 2020 10 quarters |
| ZBH Zimmer Biomet | 0.2% | 393,756 | 41.4M USD | −4.9% reduced | Q3 2020 8 quarters |
| TMO Thermo Fisher Scientific | 0.1% | 61,692 | 33.5M USD | −54.6% reduced | Q3 2021 4 quarters |
| Molson Coors Beverage Co | 0.1% | 512,602 | 27.9M USD | −5.3% reduced | Q3 2020 8 quarters |
| Huazhu Group Ltd | 0.1% | 714,058 | 27.2M USD | −2.9% reduced | Q3 2018 16 quarters |
| CB Chubb Limited | < 0.1% | 118,352 | 23.3M USD | −49.9% reduced | Q4 2021 3 quarters |
| COO Cooper Companies (The) | < 0.1% | 73,367 | 23.0M USD | −15.3% reduced | Q3 2020 8 quarters |
| VIPS Vipshop | < 0.1% | 2,171,443 | 21.5M USD | −4.2% reduced | Q2 2018 17 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 255 positions.
Breakdown by sector
- Consumer Staples 24.0%
- Health Care 16.1%
- Financials 5.7%
- Consumer Discretionary 5.0%
- Industrials 2.7%
- Technology 2.6%
- Energy 2.5%
- Communication Services 2.2%
- Utilities 1.5%
- Real Estate 1.4%
- Materials 1.2%
- not in our coverage 35.3%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors